Novo Nordisk: Passing the baton

Lars Fruergaard Jørgensen, currently executive vice president and head of Corporate Development at Novo Nordisk, will take over the helm of the Danish diabetes major. He takes over from long-time CEO Lars Rebien Sørensen.

ADVERTISEMENT

Jørgensen earned his MSc in Finance and Business Administration from Aarhus School of Business and joined Novo Nordisk right out of university in 1991. Over the years, he held several positions, including senior VP for IT & Corporate Development and Chief Information Officer. He is also chairman of the board of NNE Pharmaplan. Jørgensen is taking over from retiring Lars Rebien Sørensen, a Novo Nordisk institution. Sørensen had been with the company since 1982, and served as CEO for the last 16 years. On his way out, Sørensen is taking 1,000 of his colleagues with him. In late September, Novo Nordisk announced extensive layoffs to relieve financial pressure.

YOU DON`T WANT TO MISS ANYTHING?

Sign up for our newsletter!